Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

New hybrid compound found to effectively prevent hair loss.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

A3B5 can reduce skin pigmentation and slow melanoma growth.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

New drug uses show promise but need more research.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

GD-23 reduces anxiety by relying on neurosteroid production.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Pranlukast and mirabegron may work as new diabetes drugs.